Factors Associated with PCV13 Vaccine Hesitancy in Parents under an Innovative Immunization Strategy: a Cross-Sectional Study - Weifang City, Shandong Province, China, 2021

China CDC Wkly. 2023 Mar 24;5(12):271-277. doi: 10.46234/ccdcw2023.049.

Abstract

What is already known on this topic?: Pneumococcal diseases (PDs) are serious threats to child health. Although vaccination is one of the most effective ways to prevent these diseases, the pneumococcal vaccination coverage rate is still relatively low in China.

What is added by this report?: This study investigated the factors associated with 13-valent pneumococcal conjugate vaccine (PCV13) vaccine hesitancy in parents under an innovative immunization strategy. This study found that 29.7% of the participants hesitated to vaccinate their children against PCV13 and the main reasons for vaccine hesitancy were individual and group influences.

What are the implications for public health practice?: This study can provide scientific evidence for further improving children's PCV13 vaccination rate and improving the prevention and control strategy for PDs.

Keywords: 13-valent pneumococcal conjugate vaccine; PCV13; influencing factors; vaccine hesitancy.

Grants and funding

Supported by Education Foundation of Peking Union Medical College (WH10022021145) and Bill & Melinda Gates Foundation (OPP1216666)